The Inaugural West Coast Advancing Drug Development Forum - Making the Impossible, Possible. Like ‘The Inaugural Advancing Drug Development Forum - Making the Impossible, Possible that took place in December in Boston, this inaugural west coast forum program aims to bring together key opinion leaders in biotech and pharma, executive leadership, senior directors, consultants, and a close network of non-competitive CROs and CDMOs to explore together novel solutions, promising technology breakthroughs and how industry introduces and incorporates improved approaches in small molecule drug development.
The aim of this conference is to provide an opportunity for the world scientific community closely related to pharmaceutical research, to come together and in warm and stimulating atmosphere present their original work and share experiences and problems. More specifically, the aim of the Conference is to address the most advanced directions and new achievements in physical chemistry methods which underlie almost all instrumental techniques used in the research processes in drug discovery and pharmaceutical development.
The conference programme will have the theme “The Science of Differentiated Medicines” and is designed to build upon the FIP conference theme of “Pharmacy: transforming outcomes” by exploring how the appropriate use of medicines can help specific patient populations.
The DDF Summit brings the most innovative and exciting studies to you. Covering both small molecules and biologics, you’ll find new technologies, conceptsand case studies in areas such as formulation design for poorly soluble compounds, the potential of nanotechnology for better deliverability, the latest controlled released technologies, improving patient compliance by harnessing data and the latest smart device technology, optimising formulations for continuous manufacturing, overcoming the blood brain barrier and challenges in oral delivery of biologics, and reformulation and biosimilars.
Whether considering next steps following lead candidate selection, formulation optimization during Phase 1, 2, or 3, the likely impact of proposed post-marketing changes in product formulation or manufacture, or attempting to generate generic versions of an approved marketed drug product, an understanding of the critical factors influencing drug product absorption is essential . Such information also helps determine the method to be used for testing product in vitro drug release and the associated criteria for ensuring consistent batch-to-batch product performance.…
The programme will include presented highlights from the CMAC Future Manufacturing Research Hub, posters from all CMAC Researchers, excellent networking opportunities with internationally leading academics and industrialists, exhibitions from our world leading Tier 2 Partners, and tours of the CMAC National Facility.
Dissolution imaging/UV imaging is increasingly used in drug development for the characterization of drug substances, excipients and delivery systems. The ability to image in the UV wavelength range at the aqueous-solid (formulation) interface is key for attaining new insights in dissolution and release processes. Speakers from industry and academia will provide a thorough introduction to dissolution imaging for the new user and offer an opportunity for more experienced researchers to discuss and develop best practices. Application Chemist Breeze Outhwaite will be…